The RAPID pathway could cut the wait for Medicare coverage from over a year to about 2 months after FDA market authorization ...
CMS FDA launch pathway expedites Medicare coverage for breakthrough medical devices, enabling payment within two months of FDA authorization.
The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class ...
April 23 (Reuters) - U.S. health regulators on Thursday announced a new program to speed Medicare coverage for certain medical devices, cutting reimbursement timelines to about two months from a year ...
Certain breakthrough-designated medical devices that receive market authorization will become eligible for Medicare coverage ...
By Ahmed Aboulenein, Sneha S K and Siddhi Mahatole WASHINGTON, April 23 (Reuters) - U.S. health regulators announced a new ...
Federal regulators are proposing a new, faster Medicare coverage pathway for medical devices deemed by the FDA as ...
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
The Centers for Medicare and Medicaid Services said it developed concerns about the limited evaluation process for the ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
RAPID could enable Medicare coverage and payment as soon as two months after FDA approval, compared to a year or more with ...